Søgning på udtrykket 'ivermectin' giver 40 resultater


Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Journal of Medical Virology
22.03.2024
Journal of Medical Virology, Volume 96, Issue 3, March 2024.
Malaria Journal
23.02.2024
…hreatened by systematic non-participation. Such concerns are particularly pertinent for MDA programmes against malaria, as they require multi-day treatment over several consecutive months. Factors associated with non-participation to the MDA campaign with ivermectin (IVM) and dihydroartemisinin-piperaquine (DHP) implemented within the MASSIV cluster randomized trial were determined. . . . Methods. Coverage data was extracte…
BMC Infectious Diseases
18.11.2023
… Background. The World Health Organization has proposed that onchocerciasis elimination (interruption) of transmission be verified in 12 (approximately a third) endemic countries by 2030. The strategy to reach this goal is based on ivermectin Mass Drug Administration (MDA) with high geographical and therapeutic coverage. In addition to coverage, high levels of treatment adherence are paramount. We investigated factors associated with ivermectin intake in an area of Ghana with persist…
Lancet Infectious Diseases
8.11.2023
Moxidectin was non-inferior to ivermectin in terms of efficacy in the treatment of strongyloidiasis. Additionally, both drugs had a similar safety profile. The fixed dose and lower cost of moxidectin compared with ivermectin make it a valuable alternative for people with strongyloidiasis.
Malaria Journal
30.09.2023
. Abstract. . Background. Ivermectin (IVM) mass drug administration is a candidate complementary malaria vector control tool. Ingestion of blood from IVM treated hosts results in reduced survival in mosquitoes. Estimating bio-efficacy of IVM on wild-caught mosquitoes requires they ingest the drug in a blood meal either through a membrane or direct feeding on a treated host. The latter, has ethical implications, and the forme…
American Journal of Tropical Medicine and Hygiene
6.09.2023
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 109 Issue: 3 Pages: 650-655. .
BMJ Open
7.07.2023
…nd achieve elimination. Mass drug administration (MDA) of artemisinin-based combination therapy (ACT) is capable of reducing malaria transmission where coverage of control interventions is already high, though the impact is short-lived. Combining ACT with ivermectin, an oral endectocide shown to reduce vector survival, may increase its impact, while also treating ivermectin-sensitive co-endemic diseases and minimising the potential impact of ACT resistance in this context. . Methods and analysis. MATAMAL i…
Clinical Infectious Diseases
27.06.2023
AbstractBackgroundThe currently recommended benzimidazole monotherapy is insufficiently effective to control infection with the soil-transmitted helminth Trichuris trichiura. Ivermectin-albendazole combination has shown promising, but setting-dependent efficacy, with therapeutic underperformance in Côte d’Ivoire. We evaluated whether moxidectin-albendazole could serve as alternative to albendazole monotherapy in Côte d’Ivoire.MethodsIn this community-based randomized, placebo-controlled, parallel-gr…
Malaria Journal
25.06.2023
. Abstract. . Background. Ivermectin (22,23-dihydroavermectin B1a: H2B1a) is an endectocide used to treat worm infections and ectoparasites including lice and scabies mites. Furthermore, survival of malaria transmitting Anopheles mosquitoes is strongly decreased after feeding on humans recently treated with ivermectin. Currently, mass drug administration of ivermectin is under investigation as a potential novel malaria vecto…
Antimicrobial Agents And Chemotherapy
21.06.2023
Antimicrobial Agents and Chemotherapy, Ahead of Print.
American Journal of Tropical Medicine and Hygiene
7.06.2023
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 108 Issue: 6 Pages: 1183-1187. .
PLoS One Infectious Diseases
4.05.2023
…be, Andrea Hinas, Nicolas Delhomme, Magnus Åbrink, Staffan Svärd, Eva Tydén . Parasitic nematodes pose a significant threat to human and animal health, as well as cause economic losses in the agricultural sector. The use of anthelmintic drugs, such as Ivermectin (IVM), to control these parasites has led to widespread drug resistance. Identifying genetic markers of resistance in parasitic nematodes can be challenging, but the free-living nematode Caenorhabditis elegans provides a suitable model. In this …
Journal of the American Medical Association
22.03.2023
A Cochrane meta-analysis of 11 eligible trials examining the efficacy of ivermectin for the treatment of COVID-19 published through April 2022 concluded that ivermectin has no beneficial effect for people with COVID-19. Since May 2022, an additional 3 large randomized clinical trials including several thousand participants have been published, each reaching a similar conclusion.
Journal of the American Medical Association
22.03.2023
This platform randomized clinical trial examines the effectiveness of ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of early mild to moderate COVID-19.
Trends in Parasitology
17.02.2023
Ivermectin and moxidectin, two macrocyclic lactones (MLs), are exceptionally effective antiparasitic agents characterized by a broad spectrum of activity and a wide safety margin. Both drugs were initially developed for use in veterinary medicine for treatment of parasites in livestock and companion animals [1,2]. The first ivermectin formulation for humans was registered by Merck Laboratories in 1987 against onchocerciasis, got officially approved for its use against onchocerciasis and strongyloidiasis in …
Journal of Medical Virology
19.01.2023
Journal of Medical Virology, Accepted Article.
American Journal of Tropical Medicine and Hygiene
12.01.2023
. . Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 108 Issue: 1 Pages: 37-40. .
Malaria Journal
11.01.2023
… Abstract. . Background. Innovative vector control tools are needed to counteract insecticide resistance and residual malaria transmission. One of such innovative methods is an ivermectin (IVM) treatment to reduce vector survival. In this study, a laboratory experiment was conducted to investigate the effect of ivermectin on survivorship, fertility and egg hatchability rate of Anopheles arabiensis in Ethiopia. …
New England Journal of Medicine
14.12.2022
New England Journal of Medicine, Volume 387, Issue 24, December 2022.

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
ProMED
13.11.2022
River Blindness -- NigeriaAbstract--------Background: Onchocerciasis is endemic in most local government areas (LGAs) in Enugu and Ogun states. Most meso- and hyper-endemic LGAs have received many rounds of ivermectin mass drug administration (MDA). This study aimed to determine the current prevalence of onchocerciasis in villages in Enugu and Ogun states that were formerly highly endemic and to assess progress toward elimination of the infection in areas believed to be at high risk for persistence.Methods:
Medscape Infectious Diseases
19.09.2022
The new ivermectin paper immediately drew flak on social media, including from Gideon Meyerowitz-Katz, who described a number of weaknesses in the work, starting with the inaccurate title. .
Medscape Infectious Diseases
11.05.2022
The article was part of a special issue of Toxicology Reports on COVID-19 that has received an expression of concern; six of the eight articles still have EoCs. .
Medscape Infectious Diseases
11.04.2022
Ivermectin neither reduced hospital admissions for worsening COVID-19 nor shortened the time that infected patients spent in the emergency room, according to data from a large randomized controlled trial. .
Medscape Infectious Diseases
31.03.2022
"Now that people can dive into the details and the data, hopefully that will steer the majority of doctors away from ivermectin towards other therapies." .
Medscape Infectious Diseases
22.03.2022
Researchers at McMaster University in Ontario studied around 1,358 COVID patients who were at risk for severe disease because they had diabetes or other conditions. .
Medscape Infectious Diseases
17.03.2022
The measure also would limit pharmacists' ability to refuse to fill prescriptions for the anti-worm treatment ivermectin and other drugs for off-label uses as COVID-19 treatments. .
Medscape Infectious Diseases
18.02.2022
"The study findings do not support the use of ivermectin for patients with COVID-19," study authors conclude. .
Medscape Infectious Diseases
18.02.2022
Rates of new hydroxychloroquine (HCQ) prescriptions particularly increased in highly Republican counties after the Food and Drug Administration revoked its EUA for the drug's use in treating COVID-19. .
Medscape Infectious Diseases
9.02.2022
Oklahoma's attorney general says his office has found no legal basis for medical boards to discipline doctors who prescribe ivermectin or hydroxychloroquine for COVID-19. .
Medscape Infectious Diseases
27.01.2022
'That is something between a doctor and a patient, on what their best way forward on care is,' said Kansas state Senate committee chair Richard Hilderband, on the prescribing of ivermectin for COVID-19. .
Medscape Infectious Diseases
24.01.2022
The study, which began last summer, is attempting to provide a comprehensive assessment of the controversial treatment. .
Medscape Infectious Diseases
19.01.2022
A PLOS journal has issued an expression of concern for a 2018 paper which claimed that ivermectin could be useful as a way to control dengue fever. .
Medscape Infectious Diseases
14.01.2022
Most prescriptions are being written for COVID-19, although there's no evidence that it's effective against the virus. .
Medscape Infectious Diseases
2.12.2021
Hospitals in Montana and Idaho reported threats and harassment from public officials and family members of patients who were denied treatment with a drug not authorized to treat COVID-19.
Medscape Infectious Diseases
8.11.2021
Hospitals and doctors are facing more demands for ivermectin as a covid-19 treatment. In some Republican-dominated states, pushing for ivermectin interventions has become a conservative rallying cry.
Medscape Infectious Diseases
3.11.2021
The authors of a study purportedly showing that ivermectin could treat patients with SARS-CoV-2 have retracted their paper after acknowledging that their data were garbled.
Medscape Infectious Diseases
18.10.2021
At least two dozen lawsuits have been filed around the US, many in recent weeks, by people seeking to force hospitals to give their COVID-stricken loved ones ivermectin.
Medscape Infectious Diseases
12.10.2021
Republican state lawmakers are urging easier access for Alaskans to ivermectin amid the pandemic, though ivermectin is not authorized by the FDA for preventing or treating COVID-19.
ProMED
22.09.2021
COVID-19 -- Worldwide/UnknownWHO region (no. countries/territories):Total confirmed cases (new cases in last 24 hours) / Total deaths (new deaths in last 24 hours)--------------------------------------------------------------------------------Western Pacific Region (19): 7 974 488 (60 114) / 108 643 (931)European Region (61): 68 419 751 (129 294) / 1 313 479 (2089)South East Asia Region (10): 42 547 959 (49 037) / 669 126 (658)Eastern Mediterranean Region (22): 15 480 394 (30 417) / 283 387 (676)Region of

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2024 Dansk Selskab for Infektionsmedicin

CVR: 33634307

infmed.dk
Version: 2.12.2
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.906 s

Cookies og privatliv